SLC6A2 and myalgic encephalomeyelitis/chronic fatigue syndrome: If OI occurs when the norepinephrine transporter is inhibited, then impairments with the norepinephrine transporter could help explain the cognitive impairments and mental cloudiness associated among patients with CFS and POTS.